1. Home
  2. NUKK vs HOWL Comparison

NUKK vs HOWL Comparison

Compare NUKK & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nukkleus Inc.

NUKK

Nukkleus Inc.

HOLD

Current Price

$2.41

Market Cap

67.9M

Sector

Finance

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUKK
HOWL
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.9M
64.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NUKK
HOWL
Price
$2.41
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
1.7M
553.7K
Earning Date
02-12-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$0.53
52 Week High
$29.79
$2.38

Technical Indicators

Market Signals
Indicator
NUKK
HOWL
Relative Strength Index (RSI) 28.70 52.97
Support Level $2.10 $0.63
Resistance Level $3.87 $0.74
Average True Range (ATR) 0.41 0.06
MACD -0.06 0.03
Stochastic Oscillator 13.13 69.17

Price Performance

Historical Comparison
NUKK
HOWL

About NUKK Nukkleus Inc.

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: